APOE and atherosclerosis: Pharmacological inhibition of p110γ reduces atherosclerosis in ApoE−/− and LDLR−/− mice, and reconstitution of LDLR−/− mice with p110γ−/− mouse bone marrow leads to decreased T cell and monocyte infiltration in atherosclerotic plaques [29].